María Laura Bertolaccini

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Ricard Cervera, Rosa Serrano, Guillermo Pons‐Estel et al. · Annals of the Rheumatic Diseases · 2014 · 941 citations · Full text

Autoimmune Diseases Induced by TNF-Targeted Therapies

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Sandra Muñoz et al. · Medicine · 2007 · 735 citations

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

Giovanni Sanna, María Laura Bertolaccini, María José Cuadrado et al. · PubMed · 2003 · 485 citations

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

Hannah Cohen, Beverley J. Hunt, Maria Efthymiou et al. · The Lancet Haematology · 2016 · 393 citations · Full text

The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Arthritis & Rheumatology · 2023 · 370 citations · Full text